This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, October 29, 2010
Merck,Johnson&Johnson/Bristol-Myers Race For Hep C Drug/video
No comments:
Post a Comment